Wells Fargo has downgraded shares of Colgate-Palmolive Company (NYSE: NYSE:CL) from Equal Weight to Underweight while maintaining a price target of $100.00.
The firm's analysis suggests that the stock may experience modest downside potential, with an anticipated 6% drop from its current level.
The decision to downgrade the consumer goods giant comes amid expectations that Colgate-Palmolive is approaching a period where its organic sales growth could normalize in comparison to its peers. Additionally, Wells Fargo anticipates a potential reversion in the company's toothpaste market share.
Wells Fargo's price target of $100.00 is based on 24 times the estimated earnings per share (EPS) for the calendar year 2026, which aligns with the stock's 15-year average.
The valuation represents a 35% premium compared to the S&P 500 index, indicating that the stock is trading at a level consistent with its historical averages.
The analysis by Wells Fargo also points to a potential slowdown in gross margin (GM) expansion for Colgate-Palmolive. This is occurring at a time when some high-quality names in the industry are trading at significant discounts compared to their past valuations relative to Colgate-Palmolive.
In their comments, Wells Fargo clarified that the downgrade does not suggest that Colgate-Palmolive is a broken company. Rather, the firm's deep-dive analysis indicates that relative underperformance compared to its peers could be more pronounced in the near future.
Colgate-Palmolive reported robust growth in the second quarter of 2024, returning to mid-single-digit volume growth and expanding gross margins.
The success is attributed to innovative product launches, strategic marketing across various price points, and strong execution in developing markets.
TD Cowen increased its price target on Colgate-Palmolive to $115 while maintaining a Buy rating, and revised its earnings per share growth estimate upward to 11.1%.
Jefferies also increased the shares target of Colgate to $101, albeit with caution regarding the sustainability of such performance. Evercore ISI maintained an Outperform rating and raised the price target from $106 to $112, highlighting Colgate's strong growth prospects and high return on invested capital within the household and personal care industry.
InvestingPro Insights
While Wells Fargo's downgrade of Colgate-Palmolive reflects concerns over potential market share reversion and gross margin expansion slowdown, InvestingPro data and tips provide a broader financial perspective. With a market capitalization of $86.39 billion and a P/E ratio of 30.55, Colgate-Palmolive is trading at a valuation that is relatively high given its near-term earnings growth. However, the company's impressive gross profit margin of 59.7% over the last twelve months as of Q2 2024, and a revenue growth of 7.03% in the same period, suggest a strong underlying business performance.
InvestingPro Tips highlight that Colgate-Palmolive has not only maintained dividend payments for 54 consecutive years but has also raised its dividend for 35 consecutive years, which may appeal to income-focused investors. Additionally, the company's cash flows are sufficient to cover interest payments, indicating financial stability. It's worth noting that analysts have revised their earnings upwards for the upcoming period, reflecting potential confidence in the company's future performance.
Investors may also find solace in the fact that Colgate-Palmolive's stock generally trades with low price volatility, providing a sense of security during uncertain market conditions. For those considering an investment, it's important to take into account that there are 12 additional InvestingPro Tips available on the platform which could provide further insights into Colgate-Palmolive's financial health and stock performance.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.